---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-270867"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2024-12-05T23:59:59+00:00"
generated_at: "2026-05-29T07:41:02.599575+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CVS Health issues $3B junior subordinated notes: 7.0% due 2055, 6.75% due 2054

## Summary
- Issued $2.25B of 7.000% Series A Junior Subordinated Notes due 2055 and $750M of 6.750% Series B Junior Subordinated Notes due 2054.
- Expected net proceeds ~$2.963B after underwriting discounts and expenses.
- Closing expected December 10, 2024; lead underwriters include Barclays, Citigroup, Goldman Sachs.
- Registration statement on Form S-3ASR (File No. 333-272200) effective May 25, 2023.

## SEC filing metadata
- accession: 0001193125-24-270867
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2024-12-05T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000119312524270867/0001193125-24-270867-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000119312524270867/d910747d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-270867
- JSON: https://secwatch.observer/filing/0001193125-24-270867.json
- Plain text: https://secwatch.observer/filing/0001193125-24-270867.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.